IP Library › Assignment 065178/0965
Patent Assignment
Reel/Frame 065178/0965

Release of Security Interest

Recorded: 2023-10-06 Pages: 27
Assignor
CITIBANK, N.A.
Executed: 2023-10-06
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties (42)
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
A Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Purification of Proteins with Cationic Surfactant
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 6,576,235 →
Application: 09/370,084 →
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent: 6,783,965 →
Application: 09/501,730 →
Urate Oxidase
Patent: 7,056,713 →
Application: 09/762,097 →
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,723,089 →
Application: 09/839,946 →
Publication: US 2003/0166249
Conjugates prepared with aggregate-free proteins
Application: 10/928,370 →
Publication: US 2005/0014240
Urate oxidase
Application: 11/357,028 →
Publication: US 2006/0188971
Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase
Patent: 8,148,123 →
Application: 11/539,475 →
Publication: US 2007/0274977
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,927,589 →
Application: 11/833,590 →
Publication: US 2008/0031864
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent: 7,927,852 →
Application: 11/882,750 →
Publication: US 2008/0057048
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
Application: 11/899,688 →
Publication: US 2008/0159976
Purification of Proteins With Cationic Surfactant
Patent: 9,534,013 →
Application: 11/918,292 →
Publication: US 2009/0317889
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,811,800 →
Application: 11/918,296 →
Publication: US 2009/0209021
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,188,224 →
Application: 11/918,297 →
Publication: US 2009/0169534
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 8,067,553 →
Application: 12/769,570 →
Publication: US 2010/0323422
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 12/769,572 →
Publication: US 2010/0323423
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,964,381 →
Application: 12/879,084 →
Publication: US 2011/0104751
Fast Disintegrating Compositions of Meloxicam
Patent: 8,545,879 →
Application: 12/988,919 →
Publication: US 2012/0168335
PEG-Urate Oxidase Conjugates and Use Thereof
Patent: 8,618,267 →
Application: 13/083,152 →
Publication: US 2013/0052677
Method for Purifying Urate Oxidase Tetramers and Octamers
Patent: 8,921,064 →
Application: 13/085,793 →
Publication: US 2011/0287466
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,034,594 →
Application: 13/107,498 →
Publication: US 2011/0217755
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,178,334 →
Application: 13/226,891 →
Publication: US 2012/0070876
PEG-Urate Oxidase Conjugates and Use Thereof
Application: 13/306,336 →
Publication: US 2012/0149083
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Patent: 9,377,454 →
Application: 13/379,704 →
Publication: US 2012/0301454
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,293,228 →
Application: 13/452,151 →
Publication: US 2012/0225046
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,541,205 →
Application: 13/461,170 →
Publication: US 2012/0309085
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,465,735 →
Application: 13/623,512 →
Publication: US 2013/0084273
Variant Forms of Urate Oxidase and Use Thereof
Patent: 9,017,980 →
Application: 13/972,167 →
Publication: US 2013/0330803
Aggregate-Free Urate Oxidase For Preparation of Non-Immunogenic Polymer Conjugates
Application: 14/462,368 →
Publication: US 2014/0363414
Variant Forms of Urate Oxidase and Use Thereof
Patent: 9,670,467 →
Application: 14/671,246 →
Publication: US 2015/0197732
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 9,885,024 →
Application: 14/806,494 →
Publication: US 2016/0160188
Urate Oxidase
Application: 60/095,489 →
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 60/219,318 →
Purification of proteins with cationic surfactant
Application: 60/670,520 →
Variant form of urate oxidase and use thereof
Application: 60/670,541 →
Variant forms of urate oxidase and use thereof
Application: 60/670,573 →
Developments related to the treatment of gout
Application: 61/269,669 →
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegloticase Therapy
Application: 61/298,718 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2000
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.; HERSHFIELD, MICHAEL S.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.; DUKE UNIVERSITY
Reel/Frame 010706/0534 →
Assignment of Assignor's Interest May 22, 2000
From: SHERMAN, MERRY R., PH.D.; SAIFER, MARK G.P., PH.D.; WILLIAMS, DAVID, PH.D.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 010836/0572 →
Assignment of Assignor's Interest Feb 2, 2001
From: HERSHFIELD, MICHAEL; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 011545/0995 →
Assignment of Assignor's Interest Nov 28, 2001
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 012320/0572 →
Assignment of Assignor's Interest Nov 30, 2001
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 012320/0564 →
Assignment of Assignor's Interest May 24, 2006
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 017663/0313 →
Assignment of Assignor's Interest Aug 28, 2007
From: REHRIG, CLAUDIA D.; HUANG, WILLIAM; HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 019756/0045 →
Assignment of Assignor's Interest Oct 24, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020005/0757 →
Assignment of Assignor's Interest Oct 24, 2007
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020003/0964 →
Assignment of Assignor's Interest Nov 19, 2007
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020133/0479 →
Assignment of Assignor's Interest Nov 19, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020133/0551 →
Assignment of Assignor's Interest Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest Mar 14, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA; REHRIG, CLAUDIA D.; HUANG, WILLIAM
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020651/0468 →
Confirmatory License Jul 1, 2008
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021176/0511 →
Assignment of Assignor's Interest Jul 23, 2008
From: HERSHFIELD, MICHAEL S.
To: DUKE UNIVERSITY
Reel/Frame 021278/0683 →
Assignment of Assignor's Interest Jul 31, 2009
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 023037/0222 →
Assignment of Assignor's Interest Aug 5, 2009
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 023053/0802 →
Assignment of Assignor's Interest Dec 20, 2010
From: NEAL, GREGORY EDWARD
To: R.P. SCHERER TECHONOLOGIES, INC.
Reel/Frame 025594/0364 →
Assignment of Assignor's Interest Dec 20, 2010
From: BURNS, DAVID ALLEN
To: WILMINGTON PHARMACEUTICALS, LLC
Reel/Frame 025594/0372 →
Assignment of Assignor's Interest Aug 22, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 026783/0095 →
Assignment of Assignor's Interest Aug 22, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 026784/0154 →
Assignment of Assignor's Interest Oct 5, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 027020/0822 →
Assignment of Assignor's Interest Oct 5, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 027020/0843 →